SGLT2 Inhibition Protects Cognitive Function in Alzheimer's Disease by Enhancing Brain Perfusion, Independent of Glucose Control
This study was supported by grants AG079336, AG057842, P20GM104357, and HL138685 from the National Institutes of Health, TRIBA Faculty Startup Fund from Augusta University, and 25PRE1365157 from the American Heart Association.
Authors
- Jane J. Border
- Gilbert Charles Morgan (ORCID: https://orcid.org/0000-0003-0516-1113)
- Xing Fang
- Chengyun Tang (ORCID: https://orcid.org/0000-0001-7536-9740)
- Huawei Zhang (ORCID: https://orcid.org/0000-0003-2623-8706)
- Fan Fan (ORCID: https://orcid.org/0000-0003-1463-3610)
- Richard J. Roman
- Andrew P. Gregory
Institutions
- Augusta University (US)
- Jackson Memorial Hospital (US)
- University of Mississippi Medical Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_096815
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association
- Augusta University
- National Institutes of Health